Online Submissions

Already have a Username/Password for Archive of Clinical Cases?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.


Author Guidelines

Publication ethics and publication malpractice statement

Archive of Clinical Cases encourages authors to strive for, and adhere themselves to, the International standards for authors of scholarly research publications developed by The Committee on Publication Ethics (COPE).  

Archive of Clinical Cases follows the ICMJE's Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.

Reporting Guidelines for Case Reports according to EQUATOR Network (See CARE Checklist 2013)

Archive of Clinical Cases uses PlagScan and Copyleaks to identify paraphrased and similar content in order to detect and prevent plagiarism.

The image shows our cooperation with the online plagiarism detection service PlagScan

Title Page - indicate a concise and meaningful title for the article.

In order to assure a double blind reviewing process, the manuscript should not contain the authors' names, institutional addresses and email addresses.

Abstract should be provided on the 2nd page of the manuscript. It must include no more than 150 - 250 words. The abstract should not contain any undefined abbreviations or references.

Text Formatting All manuscripts should be submitted in Word (*.doc – older Word versions or *.docx format – Word 2007 or higher). • The text will be typed using a plain font (e.g., 12-point Times Roman). • If necessary, use italics for emphasis. • Page numbers will be inserted automatically by the page numbering function. • Field functions will be avoided. • No tab stops or other commands for indents should be used. • To design tables, use the table function, and do not import spreadsheets. • For equations, Equation Editor or MathType in word are recommended. • Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).

Abbreviations Abbreviations should be defined at first use and then consistently used. 

List of abbreviations If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations can be provided, which should precede the competing interests and authors' contributions.

Footnotes No footnotes or endnotes are allowed.

Acknowledgments Acknowledgments of people, grants, funds, etc. should be placed at the end of the manuscript right before References.

Scientific style It is compulsory to use internationally accepted signs and symbols for units (SI units).

Reference list References cited in the manuscript will be indicated in the reference list as they appear in the text. Reference list should only include works that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Self-citations are not encouraged. Other published case reports that are relevant to the presented case should be included in the reference list The entries in the list should be numbered consecutively.

Journal article

- with 1-6 authors (include all authors): Koonin EV, Altschul SF, Bork P. BRCA1 protein products: functional motifs. Nat Genet. 1996; 13:266-267.

- with more than 6 authors (include only the first 3 authors, et al.): Franssen CFM, Gans ROB, Arends B, et al. Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int. 1995; 47:193–199.

Article within a journal supplement Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I: Analysis and assessment of ab initio three-dimensional prediction, secondary structure, and contacts prediction. Proteins. 1999; 43(Suppl 3):149-170.

Published abstract Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN. Mesenchymal cells, stromal derived factor-1 and rheumatoid arthritis [abstract]. Arthritis Rheum. 1999; 42:s250.

Article in a conference proceedings Jones X. Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann; 1996:16-27.

Book Kansky J, Bowling B. Clinical Ophtalmology - A Systematic Approach, 7th Edition. Philadelphia: Elsevier Saunders, 2011.

Book chapter, or article within a book Schnepf E. From prey via endosymbiont to plastids: comparative studies in dinoflagellates. In Lewin RA (Ed.) Origins of Plastids. Volume 2. 2nd edition. New York: Chapman and Hall; 1993:53-76.

Book with institutional author Advisory Committee on Genetic Modification: Annual Report. London; 1999.

PhD thesis Kohavi R: Wrappers for performance enhancement and oblivious decision graphs. PhD thesis. Stanford University, Computer Science Department; 1995.

Link / URL National Institute of Neurological Disorders and Stroke-NINDS Neurofibromatosis Information Page [ available at mm.dd.yyyy]

Link / URL with author(s) Corpas M: The Crowdfunding Genome Project: a personal genomics community with open source values [ available at mm.dd.yyyy]

Clinical trial registration record with persistent identifier Mendelow, AD (2006): Surgical Trial in Lobar Intracerebral Haemorrhage. Current Controlled Trials. Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, as in

Tables • All tables are to be numbered using Arabic numerals. • Tables should always be cited in text in consecutive numerical order. • Each table must be provided with a caption (title) explaining the table.

Artwork and Illustrations Guidelines Electronic format submission for artwork and photographs, line drawings, is a must.

Electronic Figure Submission • Figures should have a minimum resolution of 600 dpi. • For vector graphics, the preferred format is EPS; for halftones, please use TIFF format.. • Name your figure files with "Fig" and the figure number, e.g., Fig1.eps. • Each figure must be provided with a caption (title) explaining the figure. • Figure should always be cited in text in consecutive numerical order in parentheses (Figure 1).

Line Art • Black and white graphic with no shading. • Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size. • All lines should be at least 0.1 mm (0.3 pt) wide. • Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 200 dpi. • Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc. • Combination artwork should have a minimum resolution of 600 dpi. Color Art • Color art is free of charge for online publication. • If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent. • If the figures will be printed in black and white, do not refer to color in the captions. • Color illustrations should be submitted as RGB (8 bits per channel). Figure Lettering • To add lettering, it is best to use Helvetica or Arial (sans serif fonts). • Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt). • Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label. • Avoid effects such as shading, outline letters, etc. • Do not include titles or captions within your illustrations.

Figure Numbering • All figures are to be numbered using Arabic numerals. • Figures should always be cited in text in consecutive numerical order. • Figure parts should be denoted by lowercase letters (a, b, c, etc.).

Figure Captions • Each figure should have a concise caption describing accurately what the figure depicts. Include the captions at the end of the manuscript, not in the figure file. • Figure captions begin with the term Fig., followed by the figure number

Permissions If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that UMF Gr. T Popa Publishing house will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.

Consent Manuscripts will not be peer-reviewed if a statement of patient consent/ethics committee approval is not included. This section is compulsory. It should provide a statement to confirm that the patient has given their informed consent for the case report to be published. The editorial office may request copies of the consent documentation at any time. We recommend the following wording is used for the consent section: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal." Case reports without appropriate consent will be rejected prior to peer review.


Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'.

Conflicts of interest represent - according to PLOS - any interference with the objectiveness of the information provided in the article, or possibility to be reasonably perceived as such, potentially biasing the editorial decision-making process. Conflict of interests may arise when secondary interests (such as financial benefits or personal issues) could have repercussions on professional judgment of primary interest (for example patient’s consent). As it is difficult for individual readers to objectively evaluate whether a competing interest could have influenced the presentation of, reviewing, or editors’ decision regarding publishing a given manuscript, we require the authors to fill in and submit the ICMJE Form for Disclosure of Potential Conflicts of Interest. Since competing interests arise almost inevitably, stating them allows readers to assess more precisely such bias, ensuring transparency regarding any affiliation, relevant financial interest, funding, and donation of medical equipment or other related aspects. A manuscript will not be rejected from publishing simply due to the existence of a competing interest, but failure in disclosing an up-to-date information related to the conflicts of interest may delay the evaluation process of the manuscript. The policy regarding disclosure of such information is unconcealed and applied for all submitted manuscripts: the filled-in information referring to the conflicts of interest will be published in Conflict of interests section of the article. If there is any concern or uncertainty about the relevance of a financial relationship or interest, the correspondent author should contact the editorial office.


Manuscripts will not be peer-reviewed if a statement of patient consent is not present. This section is compulsory. It should provide a statement to confirm that the patient has given their informed consent for the case report to be published. The editorial office may request copies of the consent documentation at any time. We recommend the following wording is used for the consent section: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal." Case reports without appropriate consent will be rejected prior to peer review.




Archive of Clinical Cases is an Open Access journal and publishing an article in this journal requires an Article Processing Charge (APC). APC will be billed to the submitting author only after acceptance of the manuscript for publication. Except from this Article Processing Charge there are no other fees.

The payment instructions will be provided via email to the corresponding author after the manuscript has been accepted for publication.

The Article Processing Charge is 200 Euro or the equivalent in USD or Romanian Lei.


Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The manuscript has not been previously published, nor is it under evaluation by another journal.
  2. The submited file is an OpenOffice and Microsoft Word  format.
  3. The text is single-spaced, uses a 12-point font; all illustrations, figures, and tables are placed at the end.
  4. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  5. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Copyright Notice

Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at and our digital applications is intended for personal noncommercial use.

Authors who publish in this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.

Guidelines for linking to a. The main purpose of the site linking to the Archive of Clinical Cases’s site should be educational. b. Links should be made to the Archive of Clinical Cases’s home page ( or to the article’s abstract. c. It is forbidden to use the Archive of Clinical Cases’s cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.


Privacy Statement

The names and addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will comply with national legislation on data protection and with the European Union’s General Data Protection Regulation (the ‘GDPR’) that went into effect on May 25, 2018.

Our Site is not intended for children. We do not knowingly collect or maintain the personal information of children under the age of 18. If you are under the age of 18, please do not access our Site at any time or in any manner. We will take appropriate steps to delete the personal information of persons under the age of 18.

Information We May Collect about You

We will collect any information that you provide to us when you:

- submit correspondence to us via our Site;

- register for an account with us or update your profile details;

- submit, edit or review a manuscript depending on whether you are a Submitting Author or Editor or Reviewer;

- subscribe to our mailing list;

- “follow”, “like”, post to or interact with our social media accounts, including Facebook, LinkedIn, Twitter.

The information you provide to us will include (depending on the circumstances):

- Identity and contact data: names, addresses, email address and phone number;

- Account profile data: if you are registering for an account you will also provide a username, password, ORCID ID and additional information about your academic and work history, references and any other such similar information as may be required;

- Conflicts of Interest: if you are a Submitting Author, Editor or Reviewer you are obliged to disclose any Conflicts of Interest you may have in relation to the work you are submitting or which you have been assigned to edit or review. Some of the information you disclose may constitute your Sensitive Personal Data.

Information We Collect about You

- Information transmitted on the website: we will collect information that you upload or post to your account.

Information We Receive from Third Parties

In certain circumstances, we will receive information about you from third parties. For example:

- ORCID ID: if you are a Submitting Author using the manuscript tracking system to submit a manuscript, you will be required to provide your ORCID ID. By providing your ORCID ID you are authorising that third-party provider to display certain information about you in accordance with your ORCID account settings;

- Plagiarism checking services: we also use third-party providers to verify information provided by you via your account, including via any articles you submit to us for publication. We use PlagScan software to detect instances of overlapping and similar text in submitted manuscripts. We also use other third-party databases or websites to confirm your publication history to prevent duplicate submission (including Web of Science, Scopus, PubMed).

How We Use Information about You

We will use your information for the purposes listed below either on the basis of:

- To provide access to our website: to provide you with access to our site in a manner convenient and optimal and with personalised content relevant to you;

- To register your account: when you sign up to use the manuscript tracking system, we will use the details provided on your account registration form (on the basis of performing our contract with you);

- To enable you to use the manuscript tracking system: to enable (as applicable) the receipt, review, editing, production and publication of articles in our journals, via the manuscript tracking system (on the basis of performing our contract with you);

- Research Integrity: to identity any potential or actual Conflict of Interest which may compromise the neutrality or objectivity of an article or its review (for academic publication purposes or on the basis of your consent where we have requested it);

- Relationship Management: to manage our relationship with you, which will include notifying you about changes to our Terms of Service or Privacy Policy, and asking you to leave a review or take a survey (on the basis of performing our contract with you, to comply with our legal obligations and on the basis of our legitimate interests to keep our records updated and study how our website and services are used);

- Fraud and unlawful activity detection: protect, investigate, and deter against fraudulent, unauthorised, or illegal activity, including, without limitation, plagiarism and identity fraud (on the basis of our legitimate interests to operate a safe and lawful business or where we have a legal obligation to do so).

Legitimate Interests

Where we use your information for our legitimate interests, we make sure that we take into account any potential impact that such use may have on you. Our legitimate interests don’t automatically override yours and we won’t use your information if we believe your interests should override ours unless we have other grounds to do so. If you have any concerns about our processing please refer to the “Your Rights” section below.

How We Look after Your Information and How Long We Keep It for

We operate a policy of “privacy by design” by looking for opportunities to minimise the amount of personal information we hold about you. We use appropriate technological and operational security measures to protect your information against any unauthorised access or unlawful use, such as:

- ensuring the physical and digital security of our equipment and devices by using appropriate password protection and encryption;

- limiting access to your personal information to those in our company who need to use it in the course of their work.

We will retain your information for as long as is necessary to provide you with the services that you have requested from us or long as we reasonably require to retain the information.

Help Keep Your Information Safe

You can also play a part in keeping your information safe by:

- choosing a strong account password and changing it regularly;

- using different passwords for different online accounts;

- keeping your login and password confidential and avoiding sharing these details with others;

- making sure you log out of the site each time you have finished using it. This is particularly important when using a shared computer;

- letting us know if you know or suspect that your account has been compromised, or if someone has accessed your account without your permission;

- keeping your devices protected by using the latest version of your operating system and maintaining any necessary anti-virus software.

Your Rights to the Information We Hold about You

You have certain rights in respect of the information that we hold about you, including:

- the right to be informed of the ways in which we use your information, as we seek to do in this Privacy Policy;
- the right to ask us not to process your personal data for marketing purposes;
- the right to request access to the information that we hold about you;
- the right to request that we correct or rectify any information that we hold about you which is out of date or incorrect;
- in certain circumstances, the right to ask us to stop processing information about you;

- the right to withdraw your consent for our use of your information in reliance of your consent;

- the right to object to our using your information on the basis of our legitimate interests or those of a third party;

- the right to receive a copy of any information we hold about you (or request that we transfer this to another service provider) in a structured, commonly-used, machine readable format, in certain circumstances; and

- the right to ask us to limit or cease processing or erase information we hold about you in certain circumstances.

Please note that we may need to retain certain information for our own record-keeping.

You may exercise your rights above by contacting us using the details in the “Contact Us” section.

Changes to This Privacy Policy

We may make changes to this Privacy Policy from time to time. We will post any changes to our site, or notify you of any material changes by e-mail. Any changes will come into effect the next time you engage with us after the changes have been notified.

It is important that the personal data we hold about you is accurate and current. Please keep us informed if your personal data changes during your relationship with us by updating your profile account information or contacting us via the contact details at the top of this Privacy Notice.